Literature DB >> 2544711

Heterotopic osteogenesis in porous ceramics induced by marrow cells.

H Ohgushi1, V M Goldberg, A I Caplan.   

Abstract

When untreated porous calcium phosphate ceramics were transplanted into subcutaneous (s.c.) or intramuscular (i.m.) sites, fibrovascular tissue grew in the pore region without evidence of bone formation. However, when these same ceramics were combined with syngeneic marrow cells, osteogenesis was observed inside the pore region of the implanted ceramic. The osteogenesis began on the surface of the pore region at approximately 3 weeks postimplantation by a process of intramembranous bone formation, with the de novo bone tissue observed directly interfacing with the ceramic surface. Infrequently, small isolated areas showed cartilage formation with no noticeable endochondral ossification. At 4 weeks postimplantation of the ceramic with marrow cells, the osteogenesis in the ceramic accompanied an observed increase in compressive strength, rigidity, and energy absorption of the ceramic. These results suggest that a combination of porous ceramics and marrow cells may be useful for clinical problems requiring osseous reconstruction.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2544711     DOI: 10.1002/jor.1100070415

Source DB:  PubMed          Journal:  J Orthop Res        ISSN: 0736-0266            Impact factor:   3.494


  38 in total

1.  In vitro and in vivo methods to determine the interactions of osteogenic cells with biomaterials.

Authors:  R O Oreffo; J T Triffitt
Journal:  J Mater Sci Mater Med       Date:  1999 Oct-Nov       Impact factor: 3.896

2.  Interactions of human osteoprogenitors with porous ceramic following diffusion chamber implantation in a xenogeneic host.

Authors:  R Gundle; C J Joyner; J T Triffitt
Journal:  J Mater Sci Mater Med       Date:  1997-08       Impact factor: 3.896

3.  Uncultured marrow mononuclear cells delivered within fibrin glue hydrogels to porous scaffolds enhance bone regeneration within critical-sized rat cranial defects.

Authors:  James D Kretlow; Patrick P Spicer; John A Jansen; Charles A Vacanti; F Kurtis Kasper; Antonios G Mikos
Journal:  Tissue Eng Part A       Date:  2010-10-12       Impact factor: 3.845

4.  Shed blood-derived cells from total hip arthroplasty have osteoinductive potential: a pilot study.

Authors:  Tomokazu Yoshida; Masakazu Ishikawa; Yuji Yasunaga; Takuma Yamasaki; Mitsuo Ochi
Journal:  Clin Orthop Relat Res       Date:  2010-06-24       Impact factor: 4.176

5.  The vertebral interbody grafting site's low concentration in osteogenic progenitors can greatly benefit from addition of iliac crest bone marrow.

Authors:  Mostafa Romih; Joël Delécrin; Dominique Heymann; Norbert Passuti
Journal:  Eur Spine J       Date:  2005-03-03       Impact factor: 3.134

Review 6.  Mesenchymal stem cells: lineage, plasticity, and skeletal therapeutic potential.

Authors:  Richard O C Oreffo; Cyrus Cooper; Christopher Mason; Mark Clements
Journal:  Stem Cell Rev       Date:  2005       Impact factor: 5.739

7.  Acceleration of bone formation with BMP2 in frame-reinforced carbonate apatite-collagen sponge scaffolds.

Authors:  Isao Hirata; Yuji Nomura; Manabu Ito; Atsushi Shimazu; Masayuki Okazaki
Journal:  J Artif Organs       Date:  2007-12-20       Impact factor: 1.731

8.  Nondestructive/Noninvasive Imaging Evaluation of Cellular Differentiation Progression During In Vitro Mesenchymal Stem Cell-Derived Chondrogenesis.

Authors:  Diego Correa; Rodrigo A Somoza; Arnold I Caplan
Journal:  Tissue Eng Part A       Date:  2018-01-10       Impact factor: 3.845

9.  An Attempt to Make Platelet Rich Fibrin from Bone Marrow Aspirate.

Authors:  Soh Nishimoto; Kazutoshi Fujita; Toshihiro Fujiwara; Yohei Sotsuka; Maki Tonooka; Hisako Ishise; Kenichiro Kawai; Masao Kakibuchi
Journal:  J Clin Diagn Res       Date:  2017-08-01

10.  Hydroxyapatite-glass composite as a bone substitute in large metaphyseal cavities in rabbits.

Authors:  E A Suominen; A J Aho; J Juhanoja; A Yli-Urpo
Journal:  Int Orthop       Date:  1995       Impact factor: 3.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.